Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Phobic Disorders

• Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
• D-Cycloserine and Virtual Reality Exposure Therapy
• Brief Intervention to Reduce Fear of Public Speaking
• Brief Intervention to Reduce Fear of Public Speaking
• Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
• Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
• A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
• Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
• Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a
• Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
• Ketamine Infusion for Social Anxiety Disorder
• Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
• Generalization of Extinction Learning
• Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
• Study of Vilazodone to Treat Social Anxiety Disorder
• Glucocorticoid Treatment for Social Phobia
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
• Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
• 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
• Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
• Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia
• Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
• D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
• D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
• Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
• Escitalopram in Patients With Social Anxiety Disorder
• Quetiapine in Specific Phobia
• Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
• Flushing in Social Anxiety Disorder on Seroquel
• Quetiapine in Co-Morbid Depressive and Anxiety Disorders
• D-Cycloserine Enhancement of Exposure in Social Phobia
• Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
• An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
• fMRI Study Examining Effects of D-cycloserine in Specific Phobia
• A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
• Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
• Flushing in Social Anxiety Disorder on Cipralex
• An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
• A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
• Cortisol in the Treatment of Phobias
• A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
• The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment
• A Combination Therapy In Patients With Social Anxiety Disorder
• Treatment Of Patients With Social Anxiety Disorder
• Primary Care Intervention Strategy for Anxiety Disorders
• fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
• Acamprosate in Alcoholics With Comorbid Anxiety or Depression
• Social Anxiety Disorder Study Of Paroxetine
• Efficacy of Quetiapine in Generalised Social Anxiety Disorder
• Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
• Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
• Long-term Study Of Paroxetine in Women and Men
• Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
• Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
• Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
• Nefazodone in the Treatment of Social Phobia
• Quetiapine in Social Anxiety Disorder
• Geodon for the Treatment of Refractory Social Anxiety Disorder
• Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
• Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
• Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
• RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
• Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)
• Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
• Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
• Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
• Study of Escitalopram in the Treatment of Specific Phobia
• St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
• Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
• Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
• Child and Adolescent Anxiety Disorders (CAMS)
• Treatment of Childhood Social Phobia
• St. John's Wort Versus Placebo in Social Phobia
• Treatment of Youth With ADHD and Anxiety
• Treatment for Anxiety in Children